These data suggest that platelet α-granule-derived TSP1 is a significant contributor to diet-induced NASH and fibrosis, potentially serving as a new therapeutic target for this severe liver disease. The gene discussed is THBS1; the disease is metabolic dysfunction-associated steatohepatitis.